source
- ‘There is always a first’: Why US biotech Axiom will begin its IPO journey in Hong KongAxiom Biosciences intends to pursue an IPO on the Hong Kong Stock Exchange (HKEX), followed by a co-listing on the Nasdaq—a strategy the company claims is the first U.S. biotech to use.Fierce Biotech · 8d ago↗ source
- STAT+: The next step of site-neutral, and a fiery PBM hearingMedicare proposes to reduce payments to hospitals for certain drugs and imaging services.STAT · 8d ago↗ source
- STAT+: A most-wanted fugitive appears to have been secretly working as a biotech executiveA former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech executive.STAT · 8d ago↗ source